Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia
2016 · Blood Cancer Journal · 82 citations
https://doi.org/10.1038/bcj.2016.46
T
Tilmann Bochtler
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
112
Papers
3.5K
Citations
31
h-index
46
i10-index
Tilmann Bochtler is an academic researcher from German Cancer Research Center. The author has contributed to research in topics: Cancer Diagnosis and Treatment & Acute Myeloid Leukemia Research & Amyloidosis: Diagnosis, Treatment, Outcomes. The author has an h-index of 31, co-authored 96 publications.
ORCID: 0000-0003-4162-7881Papers by this author
worksOutcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
2014 · Blood · 72 citations
https://doi.org/10.1182/blood-2013-12-544957
Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study
2024 · The Lancet · 58 citations
https://doi.org/10.1016/s0140-6736(24)00814-6
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial
2023 · Nature Communications · 31 citations
https://doi.org/10.1038/s41467-023-42400-5
185P Multi-omics profiling and clinical characterization of colon-like cancer of unknown primary (CUP)
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.2190
Etiology of TP53 mutated complex karyotype acute myeloid leukemia
2025 · Leukemia · 0 citations
https://doi.org/10.1038/s41375-025-02835-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat